glp-1 and alcohol Therapeutics Their Emerging Role in and Substance Use Disorders: An Endocrinology Primer IUPHAR review – Glucagon-like peptide-1
Description
Track your medication, your most recent shot date, shot location, dosage, and your weight
p=0.002)
Adolescents with obesity prescribed a GLP-1 receptor agonist are less likely to have suicidal ideation or a suicide attempt than those with obesity treated with lifestyle intervention, according to new data
Compounded semaglutide/tirzepatide will phase out by late May 2025, so prepare to switch to FDA-approved products
